Skip to main content

Table 3 Adverse events

From: Metoclopramide or domperidone improves post-pyloric placement of spiral nasojejunal tubes in critically ill patients: a prospective, multicenter, open-label, randomized, controlled clinical trial

Event Metoclopramide group Domperidone group Control group P value
( n = 100) ( n = 99) ( n = 99)
Any event 20 (20.0) 10 (10.1) 13 (13.1) 0.126
Drug-associated events     
 Lethargy 2 (2.0) 0 0 0.136
 Dysphoria 1 (1.0) 0 0 0.370
 Amyostasia 1 (1.0) 0 0 0.370
 Pruritus 0 1 (1.0) 0 0.365
Tube-associated events     
 Nasal mucosa bleeding 8 (8.0) 5 (5.1) 8 (8.1) 0.637
 Airway misplacement 1 (1.0) 0 1 (1.0) 0.606
 Pain 2 (2.0) 3 (3.0) 2 (2.0) 0.861
 Nausea 4 (4.0) 1 (1.0) 1 (1.0) 0.222
 Vomiting 1 (1.0) 1 (1.0) 1 (1.0) 1.000
  1. Data presented as n (%).